Breckenridge Pharmaceutical, Inc., the U.S. subsidiary of Towa International that markets, distributes, and sells generic medicines in the United States, announced today that the Food and Drug ...

Meet the experts: Chesahna Kindred, MD, is a dermatologist in Marriottsville, Maryland, who specializes in hair loss. Melissa ...

The FDA approval of Gilead’s New Drug Applications (NDAs) for Yeztugo was supported by data from the Phase 3 PURPOSE 1 and PURPOSE 2 trials conducted by Gilead.

Yeztugo® (Lenacapavir) Is Now the First and Only FDA-Approved HIV Prevention Option Offering 6 Months of Protection – Approval Based on Phase 3 PURPOSE 1 and PURPOSE 2 Data that Showed ≥99.9% ...

YUPELRI approved by China's NMPA as the first once-daily nebulized LAMA for maintenance treatment of COPD <li /> Approval triggers ...

Ocular Therapeutix is making sure its corporate vision is 20/20 as it looks forward to phase 3 data on its eye disease drug candidate Axpaxli. | Ocular Therapeutix is making sure its corporate vision ...

Los Angeles dental care experiences transformational advancement with Sargon Dental's announcement of Diamoneers technology ...

Designed to eliminate the friction of traditional video production, JoggAI combines cutting-edge AI with intuitive design to ...

Synthego, a leading provider of CRISPR solutions, today confirmed that its sale to Perceptive Advisors, a global life sciences investor known for backing leading biotech companies, is cleared to close ...

“It’s not an FDA-approved use of abortion drugs,” McIntyre told the DCNF ... All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about ...